Welcome to our dedicated page for ASE Technology Holding Co., Ltd. SEC filings (Ticker: ASX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ASE Technology Holding Co., Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ASE Technology Holding Co., Ltd.'s regulatory disclosures and financial reporting.
ASE Technology (ASX) – Form 6-K, Q2 2025 results. Consolidated revenue reached NT$150.8 bn (+2 % QoQ, +7 % YoY), driven by the core ATM business, which climbed 20 % YoY to NT$91.6 bn and now represents 61 % of sales. EMS declined 7 % YoY to NT$58.4 bn.
Group gross profit improved to NT$25.7 bn with a 17.0 % margin (+20 bp QoQ, +60 bp YoY). Operating income grew 5 % QoQ to NT$10.2 bn (6.8 % margin). Nevertheless, pretax income fell 8 % YoY and net income attributable to shareholders slipped 3 % YoY to NT$7.5 bn; basic EPS was NT$1.74.
Within ATM, testing revenue surged 32 % YoY; leading-edge packaging & testing exceeded 10 % of ATM sales versus 6 % for FY-24. Segment gross margin remained robust at 21.9 % despite a 70 bp sequential easing. EMS margin stayed low at 2.6 % and operating profit dropped 22 % YoY.
Balance sheet: cash fell to NT$72.8 bn while interest-bearing debt rose to NT$240.1 bn, lifting net-debt/equity from 0.41 to 0.52. Capex totaled US$992 m in Q2, outpacing quarterly EBITDA (US$879 m).
Guidance: Management expects Q3 2025 USD revenue to rise 12-14 % QoQ (ATM +9-11 %, EMS +18-20 %), but projects a 1.0-1.2 pp gross-margin decline and a 0.1-0.3 pp operating-margin decline. EMS margin should improve 0.3-0.5 pp.